Literature DB >> 20023263

Diagnosis of myelodysplastic syndrome among a cohort of 119 patients with fanconi anemia: morphologic and cytogenetic characteristics.

Adina M Cioc1, John E Wagner, Margaret L MacMillan, Todd DeFor, Betsy Hirsch.   

Abstract

Predisposition to myelodysplastic syndrome (MDS) and acute leukemia is a hallmark of Fanconi anemia (FA). Morphologic criteria for MDS in FA are not well established, nor is the significance of clonal chromosomal abnormalities. We reviewed bone marrow samples of 119 FA patients: 23 had MDS, with the most common subtype refractory cytopenia with multilineage dysplasia. The presence of MDS was highly correlated with the presence of clonal abnormalities. Neutrophil dysplasia and increased blasts were always associated with the presence of a clone, in contrast with dyserythropoiesis. The most frequent clones had gains of 1q and 3q and/or loss of 7. Karyotype complexity also correlated with MDS. One third of patients with 3q as a sole abnormality had no MDS; patients with 3q and an additional abnormality all had MDS. The data provide a rationale for integrating cytogenetic findings with independently evaluated morphologic findings for monitoring bone marrow status in FA.

Entities:  

Mesh:

Year:  2010        PMID: 20023263      PMCID: PMC5467447          DOI: 10.1309/AJCP7W9VMJENZOVG

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  20 in total

1.  NORMAL VARIATIONS WITH AGING OF THE AMOUNT OF HEMATOPOIETIC TISSUE IN BONE MARROW FROM THE ANTERIOR ILIAC CREST. A STUDY MADE FROM 177 CASES OF SUDDEN DEATH EXAMINED BY NECROPSY.

Authors:  R J HARTSOCK; E B SMITH; C S PETTY
Journal:  Am J Clin Pathol       Date:  1965-04       Impact factor: 2.493

2.  Genetic subtyping of Fanconi anemia by comprehensive mutation screening.

Authors:  Najim Ameziane; Abdellatif Errami; France Léveillé; Chantal Fontaine; Yne de Vries; Rosalina M L van Spaendonk; Johan P de Winter; Gerard Pals; Hans Joenje
Journal:  Hum Mutat       Date:  2008-01       Impact factor: 4.878

3.  Amplification and translocation of 3q26 with overexpression of EVI1 in Fanconi anemia-derived childhood acute myeloid leukemia with biallelic FANCD1/BRCA2 disruption.

Authors:  Stefan Meyer; William D Fergusson; Anthony D Whetton; Flavia Moreira-Leite; Stuart D Pepper; Crispin Miller; Emma K Saunders; Daniel J White; Andrew M Will; Tim Eden; Hideyuki Ikeda; Reinhard Ullmann; Seval Tuerkmen; Antje Gerlach; Eva Klopocki; Holger Tönnies
Journal:  Genes Chromosomes Cancer       Date:  2007-04       Impact factor: 5.006

4.  Evaluation of dysplastic features in myelodysplastic syndromes: experience from the morphology group of the European Working Group of MDS in Childhood (EWOG-MDS).

Authors:  A Cantù Rajnoldi; S Fenu; G Kerndrup; E R van Wering; C M Niemeyer; I Baumann
Journal:  Ann Hematol       Date:  2005-04-19       Impact factor: 3.673

Review 5.  Fanconi anemia.

Authors:  Grover C Bagby; Blanche P Alter
Journal:  Semin Hematol       Date:  2006-07       Impact factor: 3.851

Review 6.  Marrow failure.

Authors:  Grover C Bagby; Jeffrey M Lipton; Elaine M Sloand; Charles A Schiffer
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2004

7.  Myelodysplastic syndrome in children and adolescents.

Authors:  Charlotte M Niemeyer; Irith Baumann
Journal:  Semin Hematol       Date:  2008-01       Impact factor: 3.851

Review 8.  Leukemia and preleukemia in Fanconi anemia patients. A review of the literature and report of the International Fanconi Anemia Registry.

Authors:  A D Auerbach; R G Allen
Journal:  Cancer Genet Cytogenet       Date:  1991-01

Review 9.  Cancer in Fanconi anemia, 1927-2001.

Authors:  Blanche P Alter
Journal:  Cancer       Date:  2003-01-15       Impact factor: 6.860

10.  Clonal chromosomal aberrations in bone marrow cells of Fanconi anemia patients: gains of the chromosomal segment 3q26q29 as an adverse risk factor.

Authors:  Holger Tönnies; Stefanie Huber; Jörn-Sven Kuhl; Antje Gerlach; Wolfram Ebell; Heidemarie Neitzel
Journal:  Blood       Date:  2003-01-02       Impact factor: 22.113

View more
  40 in total

1.  Fell Pony syndrome: characterization of developmental hematopoiesis failure and associated gene expression profiles.

Authors:  Rebecca L Tallmadge; Tracy Stokol; Mary Jean Gould-Earley; Ed Earley; Erica J Secor; Mary Beth Matychak; M Julia B Felippe
Journal:  Clin Vaccine Immunol       Date:  2012-05-16

2.  Spontaneous abrogation of the G₂DNA damage checkpoint has clinical benefits but promotes leukemogenesis in Fanconi anemia patients.

Authors:  Raphael Ceccaldi; Delphine Briot; Jérôme Larghero; Nadia Vasquez; Catherine Dubois d'Enghien; Delphine Chamousset; Maria-Elena Noguera; Quinten Waisfisz; Olivier Hermine; Corinne Pondarre; Thierry Leblanc; Eliane Gluckman; Hans Joenje; Dominique Stoppa-Lyonnet; Gérard Socié; Jean Soulier
Journal:  J Clin Invest       Date:  2010-12-22       Impact factor: 14.808

3.  Haematopoietic cell transplantation for acute leukaemia and advanced myelodysplastic syndrome in Fanconi anaemia.

Authors:  Richard Mitchell; John E Wagner; Betsy Hirsch; Todd E DeFor; Heather Zierhut; Margaret L MacMillan
Journal:  Br J Haematol       Date:  2013-10-30       Impact factor: 6.998

Review 4.  Hematopoietic cell transplantation in Fanconi anemia: current evidence, challenges and recommendations.

Authors:  Christen L Ebens; Margaret L MacMillan; John E Wagner
Journal:  Expert Rev Hematol       Date:  2016-12-21       Impact factor: 2.929

Review 5.  Genetic predisposition to MDS: clinical features and clonal evolution.

Authors:  Alyssa L Kennedy; Akiko Shimamura
Journal:  Blood       Date:  2019-01-22       Impact factor: 22.113

6.  Alternative donor hematopoietic cell transplantation for Fanconi anemia.

Authors:  Margaret L MacMillan; Todd E DeFor; Jo-Anne H Young; Kathryn E Dusenbery; Bruce R Blazar; Arne Slungaard; Heather Zierhut; Daniel J Weisdorf; John E Wagner
Journal:  Blood       Date:  2015-03-30       Impact factor: 22.113

7.  TP53 Haploinsufficiency Rescues Emergency Granulopoiesis in FANCC-/- Mice.

Authors:  Liping Hu; Weiqi Huang; Ling Bei; Larisa Broglie; Elizabeth A Eklund
Journal:  J Immunol       Date:  2018-02-02       Impact factor: 5.422

8.  Comparable Outcomes after HLA-Matched Sibling and Alternative Donor Hematopoietic Cell Transplantation for Children with Fanconi Anemia and Severe Aplastic Anemia.

Authors:  Christen L Ebens; Todd E DeFor; Rebecca Tryon; John E Wagner; Margaret L MacMillan
Journal:  Biol Blood Marrow Transplant       Date:  2017-12-02       Impact factor: 5.742

Review 9.  Old and new tools in the clinical diagnosis of inherited bone marrow failure syndromes.

Authors:  Allison H West; Jane E Churpek
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

10.  Loss of Faap20 Causes Hematopoietic Stem and Progenitor Cell Depletion in Mice Under Genotoxic Stress.

Authors:  Tingting Zhang; Andrew F Wilson; Abdullah Mahmood Ali; Satoshi H Namekawa; Paul R Andreassen; Amom Ruhikanta Meetei; Qishen Pang
Journal:  Stem Cells       Date:  2015-05-25       Impact factor: 6.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.